Impact of secukinumab on patient-reported outcomes in moderate to severe plaque psoriasis: a review of clinical studies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of secukinumab on patient-reported outcomes in moderate to severe plaque psoriasis: a review of clinical studies

Published:2021-01-07 Issue:2 Volume:21 Page:191-200
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Galluzzo Marco¹²^ORCID,Talamonti Marina¹³^ORCID,Manfreda Valeria¹,Silvaggio Dionisio¹,Tartaglia Chiara¹,Roberto Denis⁴,Campione Elena¹³^ORCID,Bianchi Luca¹³^ORCID

Affiliation:

1. Dermatology Unit, Fondazione Policlinico “Tor Vergata”, Rome, Italy

2. Department of Experimental Medicine, University of Rome “Tor Vergata”, Rome, Italy

3. Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy

4. Child Neurology and Psychiatry Unit, Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2021.1849131

Reference63 articles.

1. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

2. Pathogenesis and clinical features of psoriasis

3. The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis

4. A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

5. Psoriasis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologics update: IL‐17 inhibitors;Dermatological Reviews;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP